PROCEPT BioRobotics Corp |
Director |
Common Stock |
164K |
$16M |
$97.54 |
Nov 7, 2024 |
By The 2:22 DNA Trust |
PROCEPT BioRobotics Corp |
Director |
Common Stock |
6.87K |
$670K |
$97.54 |
Nov 5, 2024 |
Direct |
PROCEPT BioRobotics Corp |
Director |
Stock Option (Right to Buy) |
2.53K |
$11.5K |
$4.56 |
Jun 4, 2024 |
Direct |
PROCEPT BioRobotics Corp |
Director |
Common Stock |
0 |
$0 |
$97.54 |
Nov 5, 2024 |
By White Tailed Ptarmigan, LP |
PROCEPT BioRobotics Corp |
Director |
Common Stock |
0 |
$0 |
$97.54 |
Nov 5, 2024 |
Kestrel Fund, L.P. |
PROCEPT BioRobotics Corp |
Director |
Common Stock |
0 |
$0 |
$97.54 |
Nov 5, 2024 |
Mallard Fund, L.P |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Barred Owl Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CD Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CPMG, Inc. |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Crested Crane, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Elepaio Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Gallopavo, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Kestrel Fund, LP( |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Killdeer Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Mallard Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Managed Account for Trustees of the University of Pennsylvania |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Nighthawk Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Redbird Life Sciences Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Roadrunner Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Sandpiper Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By The 2:22 DNA Trust |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Willet Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class A common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Yellow Warbler, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CD Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By CPMG, Inc. |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Kestrel Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Mallard Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Redbird Life Sciences Partners, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Willet Fund, LP |
REATA PHARMACEUTICALS INC |
Director, 10%+ Owner |
Class B common stock |
0 |
|
$172.03 |
Sep 26, 2023 |
By Yellow Warbler, LP |